Literature DB >> 9498276

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution.

M A Watson1, R K Stewart, G B Smith, T E Massey, D A Bell.   

Abstract

The association between glutathione S-transferase (GST) activity as measured by 1-chloro-2,4-dinitrobenzene (CDNB) conjugation and genotype at exon 5 and exon 6 of the human GSTP1 gene was investigated in normal lung tissue obtained from 34 surgical patients. These samples were genotyped for previously identified polymorphisms in exon 5 (Ile105Val) and exon 6 (Ala114Val) by PCR-RFLP and direct sequencing. GST enzyme activity was significantly lower among individuals with the 105 Val allele. Homozygous Ile/Ile samples (n = 18) had a mean cytosolic CDNB conjugating activity of 74.9 +/- 3.8 nmol/mg per min; heterozygotes (n = 13) had a mean specific activity of 62.1 +/- 4.2 nmol/mg per min and homozygous Val/Val (n = 3) had a mean specific activity of 52.5 +/- 4.5 nmol/mg per min. The CDNB conjugating activity measured for the Ile/Ile genotype group was significantly different from that observed in the Ile/Val group (P = 0.03), and from Ile/Val and Val/Val genotypes combined (P = 0.009). Mean GST activity values were consistently lower in individuals with genotypes containing the 105 valine allele, regardless of smoking exposure. Genotypes at codon 114 were also assessed but the mean GST activity was not significantly lower in individuals with the 114 valine allele. A new haplotype, present in two samples who were homozygous 105Ile and had a 114Val, was identified and proposed as GSTP1*D. Frequencies of the exon 5 and exon 6 polymorphisms were determined in samples obtained from European-Americans, African-Americans and Taiwanese. The differences observed were highly significant suggesting the possibility of GSTP1 genotype-associated, ethnic differences in cancer susceptibility and chemotherapeutic response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498276     DOI: 10.1093/carcin/19.2.275

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  139 in total

Review 1.  Part 1: background, methodology, and clinical adoption of pharmacogenetics.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

2.  GSTT1 and GSTM1 gene polymorphisms as major risk factors for asthma in a North Indian population.

Authors:  Niti Birbian; Jagtar Singh; Surinder Kumar Jindal; Amit Joshi; Navneet Batra; Neha Singla
Journal:  Lung       Date:  2012-04-07       Impact factor: 2.584

3.  Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population.

Authors:  Ahmet O Ada; Semih C Kunak; Figen Hancer; Emre Soydas; Sibel Alpar; Meral Gulhan; Mumtaz Iscan
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

4.  Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.

Authors:  Al-Motassem Yousef; Nailya R Bulatova; William Newman; Nancy Hakooz; Said Ismail; Hisham Qusa; Farah Zahran; Nidaa Anwar Ababneh; Farah Hasan; Imad Zaloom; Ghada Khayat; Rawan Al-Zmili; Randa Naffa; Ola Al-Diab
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

Review 5.  Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.

Authors:  Eva Bandrés; Ruth Zárate; Natalia Ramirez; Ana Abajo; Nerea Bitarte; Jesus Garíia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

6.  Associations between multiple environmental exposures and Glutathione S-Transferase P1 on persistent wheezing in a birth cohort.

Authors:  Kathy T Schroer; Jocelyn M Biagini Myers; Patrick H Ryan; Grace K LeMasters; David I Bernstein; Manuel Villareal; James E Lockey; Tiina Reponen; Sergey Grinshpun; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2008-10-31       Impact factor: 4.406

7.  Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus.

Authors:  Zdenek Kala; Jiří Dolina; Filip Marek; Lydie Izakovicova Holla
Journal:  J Hum Genet       Date:  2007-05-03       Impact factor: 3.172

8.  Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas.

Authors:  Rona Ezer; Michelle Alonso; Elaine Pereira; Mimi Kim; Jeffrey C Allen; Douglas C Miller; Elizabeth W Newcomb
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 9.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

10.  Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: results of lung cancer case-control study.

Authors:  Edyta Reszka; Wojciech Wasowicz; Jolanta Gromadzinska
Journal:  Genes Nutr       Date:  2007-10-16       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.